Here begins the text.

JP Drafts (September 30, 2019)

JP drafts for public comments, September 30 - October 30, 2019

New general information

JP drafts for public comments, September 30 - December 30, 2019

New monographs

    Briefing on Proposed Draft
     
Official Monograph “Eribulin Mesilate”

Ultraviolet-visible reference spectra
Infrared reference spectra
 

To send the comment on these drafts, the guidance is as follows:

  1. Download the form for comments in  Word format
  2. Fill in the form
  3. Prepare and attach the supportive data that scientifically validate the comment when appropriate
  4. Send it to the email address: JPdraft1909-2engpmda.go.jp

Note: For the purpose of security, this email address is partly incorrect. Please replace ● with @ when sending an email.

Related Information
 

Note: The information provided with the comment may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000046847
0
JP Drafts (September 30, 2019)
/english/rs-sb-std/standards-development/jp/pub-comments/jp/0015.html
en